WSGR Honored as a Law360 "Life Sciences Group of the Year"

On January 8, 2016, Wilson Sonsini Goodrich & Rosati was featured among the top life sciences practices in the nation as part of Law360's annual "Practice Groups of the Year" series. According to the publication, the firm was chosen for several reasons, including its successful representation of cancer treatment developer NantKwest in its $207 million initial public offering, which Law360 describes as "one of the largest IPOs in the history of the life sciences industry."

In the accompanying profile, the publication highlights the firm's two recent Federal Circuit victories for Mylan Pharmaceuticals—which were both led by partner Doug Carsten—that "helped propel WSGR to the top of the pile." Partner Vern Norviel is also noted for pushing "budding companies forward by advising them on their patent portfolios," with the profile citing his team's work on NantKwest's recent patent portfolio and its representation of Pharmacyclics in its $21 billion sale to AbbVie.

Click here to read the full Law360 profile of the firm's life sciences practice.